SCHEMBL28695162

SCHEMBL28695162

Cc1c(Oc2ccccc2)ccc([N+](=O)[O-])c1C(=O)OC(C)(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 6/20 0.45
▸ KMT2A Q03164 3/20 0.45
▸ MEN1 O00255 2/20 0.45
▸ TTR P02766 2/20 0.45
▸ ALB P02768 1/20 0.45
▸ THRB P10828 1/20 0.45
▸ HPSE Q9Y251 1/20 0.43
▸ SMN1; SMN2 Q16637 3/20 0.42
▸ NPSR1 Q6W5P4 2/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ ALDH1A1 P00352 4/20 0.41
▸ HPGD P15428 2/20 0.41
▸ LMNA P02545 2/20 0.41
▸ GRM6 O15303 1/20 0.40
▸ HTR6 P50406 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29562473 0.79 MEN1 (0.40) TDP1KMT2AMEN1TTRALB
SCHEMBL22832045 0.79 MEN1 (0.40) TDP1KMT2AMEN1TTRALB
SCHEMBL29562072 0.79 GRM6 (0.35) TDP1KMT2AMEN1SMN1; SMN2ALDH1A1
SCHEMBL22832130 0.79 GRM6 (0.35) TDP1KMT2AMEN1SMN1; SMN2ALDH1A1
SCHEMBL18153628 0.77 MEN1 (0.57) TDP1KMT2AMEN1TTRALB
SCHEMBL22831952 0.77 TDP1 (0.38) TDP1THRBNPSR1ALDH1A1LMNA
SCHEMBL29561777 0.77 TDP1 (0.38) TDP1THRBNPSR1ALDH1A1LMNA
SCHEMBL22831965 0.76 LMNA (0.35) TDP1KMT2AMEN1TTRSMN1; SMN2
SCHEMBL22832036 0.76 LMNA (0.35) KMT2ASMN1; SMN2NPSR1ALDH1A1HPGD
SCHEMBL22831931 0.76 LMNA (0.35) KMT2AMEN1SMN1; SMN2NPSR1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114026073-A Quinazolin-4-one derivatives for the treatment of BRAF related diseases and disorders ARRAY生物制药公司 2022-02-08 — — CN disclosed
Send feedback